Board team

Group Founder

Stanley Chang

• MD in Medicine (National Taiwan University College of Medicine)
• Ph.D. in Biophysics (UCL, University of London, UK)

Stanley has more than 40 years of experience in the biomedical industry. He began his career at National Taiwan University Hospital as a resident and a chief resident in the department of urology. He also served as the chairman of department of urology at Tzu-Chi General Hospital. He established Medigen Biotechnology Corp. (MBC) focusing on the development of new therapies for liver diseases and cancers. in late 1999. MBC has now gradually developed into a comprehensive biopharmaceutical corporation with business fields covering new drug development, innovative drug discovery, molecular diagnostics, vaccine, and generic drugs.

Head of General Screening

Peter Lai

• President of WinMEMS Technologies
• Ph.D. in Electrical Engineering (University of Southern California)

Dr. Lai first joined Vincera Ventures in 1998 after graduating from the University of Southern California. He was responsible for investing in many companies in the USA and Taiwan, and also as a Board member. In 2008, he founded WinMEMS Technologies to start his entrepreneurship. In the past years, he led WinMEMS to develop the multiplex diagnostic platform, so-called the EMMB (EdgeCode Multiplex Magnetic Bead) system. He is also the principal inventor of the EdgeCode patent.  WinMEMS was acquired by U-Gen in 2021 and Dr. Lai keeps leading this company as the CEO and is in charge of the business of U-Gen for general screening projects.

Board

Robert Law

• Chairman of Daiyo Co., Ltd. and Win Master Group, HK, engaged in textile industry and real estate development and investment
• Chairman of Canada Mass Well Real Estate Development Company
• Chairman of Beijing Aoluo Trading Co., Ltd., franchising the production and sales of products for the 2008 Beijing Olympic Games

Board

Yiu-Kay Lai

• PhD in Genetics, North Carolina State University, USA
• Postdoctor, Yale University, USA
• Emeritus professor, Institute of Biotechnology, National Tsing Hua University, Taiwan
• 　
• Over 110 SCI papers published
• Over 40 years experience in biotechnology education and medicine & biotechnology industry

BOARD

Yang Jian

• B.B.A in Finance (Shandong University)
• Executive director – Jiuding Huaxin (Beijing)
• Deputy General Manager – Dong Yuan Hua Xin Capitals, Beijing, China

BOARD

Feng Lin Jun

• Master of Finance (Chinese University of Hong Kong)
• Public Accountants of Australia and Finance Accountants of UK
• Tutor of Tsinghua University School of Economics and Management
• Certified counsel in China
• 15 years of counsel experience in the capital market